We are monitoring the impact of COVID-19 on Middle East & Africa Lidocaine Ointment Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 5339
Share on
Share on

Middle East & Africa Lidocaine Ointment Market Research Report - Segmented By Formulation, Application & Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Growth, Trends, Forecasts | 2021 to 2026

Pulished: April, 2021
ID: 5339
Pages: 145

Middle East & Africa Lidocaine Ointment Market Size & Growth (2021 to 2026):

As Per the Report, the Size of the Middle East & Africa Lidocaine Ointment Market was valued at USD 68.34 Million in 2021 and is poised to reach USD 93.48 Million by 2026, to grow at a CAGR of 6.47% during the forecast period 2021 to 2026.

Lidocaine is a medicinal drug used to numb tissues. It is also known as xylocaine and lignocaine. Lidocaine blocks sodium channels and thus local neurons cannot signal the brain. It is used to relieve pain and irritation caused due to insect bites, minor cuts, sore mouth and sun burn, etc.

The significant drivers are increasing use of lidocaine ointment in cosmetic industry for pain relief and growing demand for lidocaine ointment as an anti-itching and pain relief medicine for insect bites, burns, skin scrape and minor cuts etc. Increasing R&D, rise in disposable income and growing awareness is also expected to drive the market over the forecast period. Strict regulations regarding safety and efficacy of the lidocaine ointment are major restraints limiting this industry.

This research report on the Middle East & Africa Lidocaine Ointment Market segmented and sub-segmented into the following categories

By Formulation:

  • Internal Use
  • Topical Use

By Application:

  • Medical
  • Cosmetics

By Country:

  • KSA
  • UAE
  • Israel
  • the rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

On the basis of region, the Middle East and Africa have an untapped market and key players are slowly expanding to this region which is the main reason for the growth of market in this region.

Key Market Companies dominating the Middle East & Africa Lidocaine Ointment Market Profiled in the Report are AstraZeneca Plc., Glenmark Pharmaceuticals, Teligent, Inc., Proficient Rx LP, ., Septodont Healthcare India Pvt. Ltd., Gemini Pharmaceuticals,  Amneal Pharmaceuticals LLC, Taro Pharmaceuticals U.S.A. Inc., Novocol Inc. and  Centura Pharmaceuticals, Inc.,

1. Introduction        

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemiology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Formulation      

       5.1.1 Introduction           

       5.1.2 Internal Use           

       5.1.3 Topical Use             

       5.1.4  Y-o-Y Growth Analysis, By Formulation      

       5.1.5  Market Attractiveness Analysis, By Formulation    

       5.1.6  Market Share Analysis, By Formulation     

                5.2 Application                 

                           5.2.1 Introduction           

5.2.2 Cosmetics

5.2.3 Medical    

5.2.4 Others      

5.2.5 Y-o-Y Growth Analysis, By Application         

5.2.6 Market Attractiveness Analysis, By Application       

5.2.7 Market Share Analysis, By Application        

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Geographical Area

                       6.1.3.2 By Formulation

                       6.1.3.3 By Application

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Geographical Area

                       6.1.4.2 By Formulation

                       6.1.4.3 By Application

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Geographical Area

                       6.1.5.2 By Formulation

                       6.1.5.3 By Application

                6.2 Middle-East       

                6.3 Africa   

7. Strategic Analysis              

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8. Market Leaders' Analysis               

                8.1 AstraZeneca Plc.                       

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Centura Pharmaceuticals, Inc.   

                8.3 Amneal Pharmaceuticals LLC      

                8.4 Gemini Pharmaceuticals, Inc.     

                8.5 Glenmark Pharmaceuticals                  

                8.6 Novocol Inc.      

                8.7 Proficient Rx LP

                8.8 Septodont Healthcare India Pvt. Ltd.      

                8.9 Taro Pharmaceuticals U.S.A., Inc.                      

                8.10 Teligent, Inc.   

9. Competitive Landscape                  

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures

                9.4 New Product Launches

10. Market Outlook and Investment Opportunities                

Appendix                  

                a) List of Tables                

                b) List of Figures     

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • The segment-level analysis in terms of product type and Packaged Containers along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Middle East and Africa Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  2. Middle East and Africa Internal Use Market By Region, From 2021 to 2026 ( USD Million )
  3. Middle East and Africa Insulin Delivery Market By Region, From 2021 to 2026 ( USD Million )
  4. Middle East and Africa Topical Use Market By Region, From 2021 to 2026 ( USD Million )
  5. Middle East and Africa Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  6. Middle East and Africa Cosmetics Market By Region, From 2021 to 2026 ( USD Million )
  7. Middle East and Africa Medical Market By Region, From 2021 to 2026 ( USD Million )
  8. Middle East and Africa Others Market By Region, From 2021 to 2026 ( USD Million )
  9. Middle East Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  10. Middle East Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )
  11. Africa Lidocaine Ointment  Market By Formulation, From 2021 to 2026 ( USD Million )
  12. Africa Lidocaine Ointment  Market By Application, From 2021 to 2026 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample